Information Advantage For Biosciences

Our analyst-grade AI spots disruptions before they become news — so you act while others react.
Trusted by leaders in biosciences

Build your 24/7 Analyst to spot trial risks before anyone else.

Build Your Analyst
Track early risks in global pivotal trials testing novel oncology targets.
Analyzing...
Analyst Configurations
  • Therapeutic Areas
    Covers all real-time updates related to Oncology, including both solid tumors and hematologic.
  • Interventions & Targets
    Focus on novel or first-in-class targets with no prior regulatory approval.
  • Trial Phases
    Only pivotal Phase III or Phase II/III studies aimed at regulatory approval.
  • Geography
    Trials must include sites in at least three major global regions (e.g., North America, Europe, Asia).
  • Events
    Track signals of trial disruption or early risk: major enrollment shifts, timeline deviations, suspensions, terminations, or withdrawals.
Review & Deploy Analyst

Always-On. Contextual. Role-Relevant Intelligence.

Stay Ahead With Always-On Intelligence

AppliedXL continuously monitors clinical, regulatory, and scientific signals—so you see execution risks and trial shifts the moment they happen, not weeks later.

Understand the Why With Context That Matters

Every update is backed by sources, enriched with historical patterns, and explained in plain English—so you know what happened, why it matters, and what to watch next.

Focus Only on What Matters to You

AppliedXL continuously monitors clinical, regulatory, and scientific signals—so you see execution risks and trial shifts the moment they happen, not weeks later.

Faster insights. Stronger growth.

Join 200+ teams working 35% faster and unlocking upside months earlier.

Latest Updates